How This Evidence Evolved
Opioid-Sparing ED Analgesia
Ending the opioid-first culture in acute pain management
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
Pain reduction comparable between subdissociative ketamine 0.3 mg/kg and morphine 0.1 mg/kg at 30 minutes
No significant difference in pain reduction between 10mg, 15mg, and 30mg ketorolac doses
Pain reduction at 2 h: ibu/APAP 4.3, oxy/APAP 4.4, hydro/APAP 3.5, codeine/APAP 3.9 (P=.053)
Integration into clinical practice guidelines and recommendations
For adult outpatient acute pain, maximize suitable nonopioid therapies; opioids only if benefits outweigh risks.
Current standard of care and ongoing research directions
Landmark Trials in This Story
Intravenous Subdissociative-Dose Ketamine Versus Morphine for Analgesia in the Emergency Department: A Randomized Controlled Trial
Pain reduction comparable between subdissociative ketamine 0.3 mg/kg and morphine 0.1 mg/kg at 30 minutes
Comparison of Intravenous Ketorolac at Three Single-Dose Regimens for Treating Acute Pain in the Emergency Department: A Randomized Controlled Trial
No significant difference in pain reduction between 10mg, 15mg, and 30mg ketorolac doses
Effect of a Single Dose of Oral Opioid and Nonopioid Analgesics on Acute Extremity Pain in the Emergency Department: A Randomized Clinical Trial
Pain reduction at 2 h: ibu/APAP 4.3, oxy/APAP 4.4, hydro/APAP 3.5, codeine/APAP 3.9 (P=.053)
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.